Covid-19 Impact on Global Bacteriophage Therapy Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Bacteriophage Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bacteriophage Therapy Revenue
1.4 Covid-19 Implications on Market by Route of Administration
1.4.1 Global Bacteriophage Therapy Market Size Growth Rate by Route of Administration: 2020 VS 2026
1.4.2 Oral
1.4.3 Topical
1.4.4 Parenteral
1.5 Market by Application
1.5.1 Global Bacteriophage Therapy Market Share by Application: 2020 VS 2026
1.5.2 Organ Transplantation
1.5.3 Bacterial Infections
1.5.4 Alcoholic Hepatitis
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Bacteriophage Therapy Industry Impact
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Covid-19 Implications on Global Bacteriophage Therapy Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Bacteriophage Therapy Growth Trends by Regions
2.2.1 Bacteriophage Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bacteriophage Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Bacteriophage Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Bacteriophage Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Bacteriophage Therapy Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
3.1 Global Top Bacteriophage Therapy Players by Market Size
3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2015-2020)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bacteriophage Therapy Market Concentration Ratio
3.2.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2019
3.3 Bacteriophage Therapy Key Players Head office and Area Served
3.4 Key Players Bacteriophage Therapy Product Solution and Service
3.5 Date of Enter into Bacteriophage Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Route of Administration (2015-2026)
4.1 Global Bacteriophage Therapy Historic Market Size by Route of Administration (2015-2020)
4.2 Global Bacteriophage Therapy Forecasted Market Size by Route of Administration (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Bacteriophage Therapy Market Size by Application (2015-2020)
5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
6.1 North America Bacteriophage Therapy Market Size (2015-2020)
6.2 Bacteriophage Therapy Key Players in North America (2019-2020)
6.3 North America Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
6.4 North America Bacteriophage Therapy Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
7.1 Europe Bacteriophage Therapy Market Size (2015-2020)
7.2 Bacteriophage Therapy Key Players in Europe (2019-2020)
7.3 Europe Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
7.4 Europe Bacteriophage Therapy Market Size by Application (2015-2020)
8 China Impact of COVID-19
8.1 China Bacteriophage Therapy Market Size (2015-2020)
8.2 Bacteriophage Therapy Key Players in China (2019-2020)
8.3 China Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
8.4 China Bacteriophage Therapy Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
9.1 Japan Bacteriophage Therapy Market Size (2015-2020)
9.2 Bacteriophage Therapy Key Players in Japan (2019-2020)
9.3 Japan Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
9.4 Japan Bacteriophage Therapy Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
10.1 Southeast Asia Bacteriophage Therapy Market Size (2015-2020)
10.2 Bacteriophage Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bacteriophage Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Bacteriophage Therapy Market Size by Application (2015-2020)
11 India Impact of COVID-19
11.1 India Bacteriophage Therapy Market Size (2015-2020)
11.2 Bacteriophage Therapy Key Players in India (2019-2020)
11.3 India Bacteriophage Therapy Market Size by Type (2015-2020)
11.4 India Bacteriophage Therapy Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
12.1 Central & South America Bacteriophage Therapy Market Size (2015-2020)
12.2 Bacteriophage Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Bacteriophage Therapy Market Size by Type (2015-2020)
12.4 Central & South America Bacteriophage Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Armata Pharmaceuticals, Inc.
13.1.1 Armata Pharmaceuticals, Inc. Company Details
13.1.2 Armata Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction
13.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2015-2020))
13.1.5 Armata Pharmaceuticals, Inc. Recent Development and Reaction to COVID-19
13.2 Eliava Biopreparations Ltd.
13.2.1 Eliava Biopreparations Ltd. Company Details
13.2.2 Eliava Biopreparations Ltd. Business Overview and Its Total Revenue
13.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction
13.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
13.2.5 Eliava Biopreparations Ltd. Recent Development and Reaction to COVID-19
13.3 Pherecydes Pharma
13.3.1 Pherecydes Pharma Company Details
13.3.2 Pherecydes Pharma Business Overview and Its Total Revenue
13.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction
13.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2015-2020)
13.3.5 Pherecydes Pharma Recent Development and Reaction to COVID-19
13.4 Intralytix, Inc.
13.4.1 Intralytix, Inc. Company Details
13.4.2 Intralytix, Inc. Business Overview and Its Total Revenue
13.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction
13.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
13.4.5 Intralytix, Inc. Recent Development and Reaction to COVID-19
13.5 Phagelux Inc.
13.5.1 Phagelux Inc. Company Details
13.5.2 Phagelux Inc. Business Overview and Its Total Revenue
13.5.3 Phagelux Inc. Bacteriophage Therapy Introduction
13.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
13.5.5 Phagelux Inc. Recent Development and Reaction to COVID-19
13.6 Nextbiotics
13.6.1 Nextbiotics Company Details
13.6.2 Nextbiotics Business Overview and Its Total Revenue
13.6.3 Nextbiotics Bacteriophage Therapy Introduction
13.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2015-2020)
13.6.5 Nextbiotics Recent Development and Reaction to COVID-19
13.7 InnoPhage, Ltd
13.7.1 InnoPhage, Ltd Company Details
13.7.2 InnoPhage, Ltd Business Overview and Its Total Revenue
13.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction
13.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2015-2020)
13.7.5 InnoPhage, Ltd Recent Development and Reaction to COVID-19
13.8 Locus Biosciences, Inc.
13.8.1 Locus Biosciences, Inc. Company Details
13.8.2 Locus Biosciences, Inc. Business Overview and Its Total Revenue
13.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction
13.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
13.8.5 Locus Biosciences, Inc. Recent Development and Reaction to COVID-19
13.9 TechnoPhage
13.9.1 TechnoPhage Company Details
13.9.2 TechnoPhage Business Overview and Its Total Revenue
13.9.3 TechnoPhage Bacteriophage Therapy Introduction
13.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2015-2020)
13.9.5 TechnoPhage Recent Development and Reaction to COVID-19
13.10 Eligo Bioscience SA
13.10.1 Eligo Bioscience SA Company Details
13.10.2 Eligo Bioscience SA Business Overview and Its Total Revenue
13.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction
13.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2015-2020)
13.10.5 Eligo Bioscience SA Recent Development and Reaction to COVID-19
13.11 Phagomed Biopharma GmbH.
10.11.1 Phagomed Biopharma GmbH. Company Details
10.11.2 Phagomed Biopharma GmbH. Business Overview and Its Total Revenue
10.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction
10.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2015-2020)
10.11.5 Phagomed Biopharma GmbH. Recent Development and Reaction to COVID-19
13.12 PhagePro, Inc.
10.12.1 PhagePro, Inc. Company Details
10.12.2 PhagePro, Inc. Business Overview and Its Total Revenue
10.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction
10.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
10.12.5 PhagePro, Inc. Recent Development and Reaction to COVID-19
13.13 Adaptive Phage Therapeutics, Inc.
10.13.1 Adaptive Phage Therapeutics, Inc. Company Details
10.13.2 Adaptive Phage Therapeutics, Inc. Business Overview and Its Total Revenue
10.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction
10.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
10.13.5 Adaptive Phage Therapeutics, Inc. Recent Development and Reaction to COVID-19
13.14 EnBiotix, Inc.
10.14.1 EnBiotix, Inc. Company Details
10.14.2 EnBiotix, Inc. Business Overview and Its Total Revenue
10.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction
10.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
10.14.5 EnBiotix, Inc. Recent Development and Reaction to COVID-19
13.15 Intodeworld, Inc.
10.15.1 Intodeworld, Inc. Company Details
10.15.2 Intodeworld, Inc. Business Overview and Its Total Revenue
10.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction
10.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
10.15.5 Intodeworld, Inc. Recent Development and Reaction to COVID-19
13.16 BiomX Ltd.
10.16.1 BiomX Ltd. Company Details
10.16.2 BiomX Ltd. Business Overview and Its Total Revenue
10.16.3 BiomX Ltd. Bacteriophage Therapy Introduction
10.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
10.16.5 BiomX Ltd. Recent Development and Reaction to COVID-19
13.17 Phi Therapeutics
10.17.1 Phi Therapeutics Company Details
10.17.2 Phi Therapeutics Business Overview and Its Total Revenue
10.17.3 Phi Therapeutics Bacteriophage Therapy Introduction
10.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2015-2020)
10.17.5 Phi Therapeutics Recent Development and Reaction to COVID-19
13.18 Fixed-phage Ltd.
10.18.1 Fixed-phage Ltd. Company Details
10.18.2 Fixed-phage Ltd. Business Overview and Its Total Revenue
10.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction
10.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
10.18.5 Fixed-phage Ltd. Recent Development and Reaction to COVID-19
13.19 Micreos BV
10.19.1 Micreos BV Company Details
10.19.2 Micreos BV Business Overview and Its Total Revenue
10.19.3 Micreos BV Bacteriophage Therapy Introduction
10.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2015-2020)
10.19.5 Micreos BV Recent Development and Reaction to COVID-19
13.20 ContraFect Corporation
10.20.1 ContraFect Corporation Company Details
10.20.2 ContraFect Corporation Business Overview and Its Total Revenue
10.20.3 ContraFect Corporation Bacteriophage Therapy Introduction
10.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2015-2020)
10.20.5 ContraFect Corporation Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Bacteriophage Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Bacteriophage Therapy Revenue
Table 3. Ranking of Global Top Bacteriophage Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bacteriophage Therapy Market Size Growth Rate by Route of Administration (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Topical
Table 7. Key Players of Parenteral
Table 8. COVID-19 Impact Global Market: (Four Bacteriophage Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Bacteriophage Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Bacteriophage Therapy Players to Combat Covid-19 Impact
Table 13. Global Bacteriophage Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Bacteriophage Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Bacteriophage Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Bacteriophage Therapy Market Share by Regions (2015-2020)
Table 17. Global Bacteriophage Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Bacteriophage Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Bacteriophage Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Bacteriophage Therapy Players
Table 24. Global Bacteriophage Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Bacteriophage Therapy Market Share by Players (2015-2020)
Table 26. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriophage Therapy as of 2019)
Table 27. Global Bacteriophage Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Bacteriophage Therapy Product Solution and Service
Table 30. Date of Enter into Bacteriophage Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 33. Global Bacteriophage Therapy Market Size Share by Route of Administration (2015-2020)
Table 34. Global Bacteriophage Therapy Revenue Market Share by Route of Administration (2021-2026)
Table 35. Global Bacteriophage Therapy Market Size Share by Application (2015-2020)
Table 36. Global Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Bacteriophage Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 40. North America Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 41. North America Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 42. North America Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Bacteriophage Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 46. Europe Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 47. Europe Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 48. Europe Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Bacteriophage Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 52. China Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 53. China Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 54. China Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Bacteriophage Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 58. Japan Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 59. Japan Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 60. Japan Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Bacteriophage Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 64. Southeast Asia Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 65. Southeast Asia Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 66. Southeast Asia Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Bacteriophage Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 70. India Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 71. India Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 72. India Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Bacteriophage Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Bacteriophage Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Bacteriophage Therapy Market Share (2019-2020)
Table 76. Central & South America Bacteriophage Therapy Market Size by Route of Administration (2015-2020) (Million US$)
Table 77. Central & South America Bacteriophage Therapy Market Share by Route of Administration (2015-2020)
Table 78. Central & South America Bacteriophage Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Bacteriophage Therapy Market Share by Application (2015-2020)
Table 80. Armata Pharmaceuticals, Inc. Company Details
Table 81. Armata Pharmaceuticals, Inc. Business Overview
Table 82. Armata Pharmaceuticals, Inc. Product
Table 83. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 84. Armata Pharmaceuticals, Inc. Recent Development
Table 85. Eliava Biopreparations Ltd. Company Details
Table 86. Eliava Biopreparations Ltd. Business Overview
Table 87. Eliava Biopreparations Ltd. Product
Table 88. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 89. Eliava Biopreparations Ltd. Recent Development
Table 90. Pherecydes Pharma Company Details
Table 91. Pherecydes Pharma Business Overview
Table 92. Pherecydes Pharma Product
Table 93. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 94. Pherecydes Pharma Recent Development
Table 95. Intralytix, Inc. Company Details
Table 96. Intralytix, Inc. Business Overview
Table 97. Intralytix, Inc. Product
Table 98. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 99. Intralytix, Inc. Recent Development
Table 100. Phagelux Inc. Company Details
Table 101. Phagelux Inc. Business Overview
Table 102. Phagelux Inc. Product
Table 103. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 104. Phagelux Inc. Recent Development
Table 105. Nextbiotics Company Details
Table 106. Nextbiotics Business Overview
Table 107. Nextbiotics Product
Table 108. Nextbiotics Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 109. Nextbiotics Recent Development
Table 110. InnoPhage, Ltd Company Details
Table 111. InnoPhage, Ltd Business Overview
Table 112. InnoPhage, Ltd Product
Table 113. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 114. InnoPhage, Ltd Recent Development
Table 115. Locus Biosciences, Inc. Business Overview
Table 116. Locus Biosciences, Inc. Product
Table 117. Locus Biosciences, Inc. Company Details
Table 118. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 119. Locus Biosciences, Inc. Recent Development
Table 120. TechnoPhage Company Details
Table 121. TechnoPhage Business Overview
Table 122. TechnoPhage Product
Table 123. TechnoPhage Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 124. TechnoPhage Recent Development
Table 125. Eligo Bioscience SA Company Details
Table 126. Eligo Bioscience SA Business Overview
Table 127. Eligo Bioscience SA Product
Table 128. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 129. Eligo Bioscience SA Recent Development
Table 130. Phagomed Biopharma GmbH. Company Details
Table 131. Phagomed Biopharma GmbH. Business Overview
Table 132. Phagomed Biopharma GmbH. Product
Table 133. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 134. Phagomed Biopharma GmbH. Recent Development
Table 135. PhagePro, Inc. Company Details
Table 136. PhagePro, Inc. Business Overview
Table 137. PhagePro, Inc. Product
Table 138. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 139. PhagePro, Inc. Recent Development
Table 140. Adaptive Phage Therapeutics, Inc. Company Details
Table 141. Adaptive Phage Therapeutics, Inc. Business Overview
Table 142. Adaptive Phage Therapeutics, Inc. Product
Table 143. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 144. Adaptive Phage Therapeutics, Inc. Recent Development
Table 145. EnBiotix, Inc. Company Details
Table 146. EnBiotix, Inc. Business Overview
Table 147. EnBiotix, Inc. Product
Table 148. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 149. EnBiotix, Inc. Recent Development
Table 150. Intodeworld, Inc. Company Details
Table 151. Intodeworld, Inc. Business Overview
Table 152. Intodeworld, Inc. Product
Table 153. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 154. Intodeworld, Inc. Recent Development
Table 155. BiomX Ltd. Company Details
Table 156. BiomX Ltd. Business Overview
Table 157. BiomX Ltd. Product
Table 158. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 159. BiomX Ltd. Recent Development
Table 160. Phi Therapeutics Company Details
Table 161. Phi Therapeutics Business Overview
Table 162. Phi Therapeutics Product
Table 163. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 164. Phi Therapeutics Recent Development
Table 165. Fixed-phage Ltd. Company Details
Table 166. Fixed-phage Ltd. Business Overview
Table 167. Fixed-phage Ltd. Product
Table 168. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 169. Fixed-phage Ltd. Recent Development
Table 170. Micreos BV Company Details
Table 171. Micreos BV Business Overview
Table 172. Micreos BV Product
Table 173. Micreos BV Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 174. Micreos BV Recent Development
Table 175. ContraFect Corporation Company Details
Table 176. ContraFect Corporation Business Overview
Table 177. ContraFect Corporation Product
Table 178. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2015-2020) (Million US$)
Table 179. ContraFect Corporation Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

List of Figures
Figure 1. Global Bacteriophage Therapy Market Share by Route of Administration: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Topical Features
Figure 4. Parenteral Features
Figure 5. Global Bacteriophage Therapy Market Share by Application: 2020 VS 2026
Figure 6. Organ Transplantation Case Studies
Figure 7. Bacterial Infections Case Studies
Figure 8. Alcoholic Hepatitis Case Studies
Figure 9. Other Case Studies
Figure 10. Bacteriophage Therapy Report Years Considered
Figure 11. Global Bacteriophage Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bacteriophage Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Bacteriophage Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bacteriophage Therapy Market Share by Players in 2019
Figure 16. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacteriophage Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2019
Figure 18. North America Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bacteriophage Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Armata Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 27. Eliava Biopreparations Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 29. Pherecydes Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 31. Intralytix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 33. Phagelux Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 35. Nextbiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 37. InnoPhage, Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 39. Locus Biosciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 41. TechnoPhage Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 43. Eligo Bioscience SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 45. Phagomed Biopharma GmbH. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 47. PhagePro, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 49. Adaptive Phage Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 51. EnBiotix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 53. Intodeworld, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 55. BiomX Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 57. Phi Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 59. Fixed-phage Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 61. Micreos BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 63. ContraFect Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs